Exchange: NASDAQ·Updated 08:11 AM EDT
News
all
press releases
Dermata Therapeutics Stock Surges 27% Pre-Market: Why is it Moving?
Dermata Therapeutics shares jumped 28.73% pre-market after reporting second-quarter results and preparing for its upcoming skincare product launch.read more...
Benzinga
More News
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Dermata Therapeutics (NASDAQ:DRMA) stock moved upwards by 44.4% to $1.56 during Tuesday's after-market session. The company's market cap stands at $4.5 million. As per the news, the Q2 earnings reportread more...
Benzinga
Dermata Therapeutics Announces A Private Placement Valued At Up To $12.4 Mln
(RTTNews) - Dermata Therapeutics Inc. (DRMA), a dermatologic firm, announced that it has entered into definitive agreements for the issuance and sale of an aggregate of 2.02 million shares of common...
Nasdaq News: Markets
Why Is Dermata Therapeutics Stock Surging Wednesday?
Dermata Therapeutics rose after announcing a private placement offering of common shares, Series C warrants, and Series D warrants.read more...
Benzinga
Why Did Dermata Therapeutics Stock Surge 22% Pre-Market Today?
The company has entered into definitive agreements to issue roughly 2.02 million shares of its common stock in a private placement deal.
Stocktwits

Advertisement|Remove ads.